Literature DB >> 2219251

Control of red cell production: the roles of programmed cell death (apoptosis) and erythropoietin.

M J Koury1, M C Bondurant.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2219251     DOI: 10.1046/j.1537-2995.1990.30891020321.x

Source DB:  PubMed          Journal:  Transfusion        ISSN: 0041-1132            Impact factor:   3.157


× No keyword cloud information.
  15 in total

1.  Adherence to macrophages in erythroblastic islands enhances erythroblast proliferation and increases erythrocyte production by a different mechanism than erythropoietin.

Authors:  Melissa M Rhodes; Prapaporn Kopsombut; Maurice C Bondurant; James O Price; Mark J Koury
Journal:  Blood       Date:  2007-11-09       Impact factor: 22.113

Review 2.  Erythropoietin or darbepoetin for patients with cancer.

Authors:  Thomy Tonia; Annette Mettler; Nadège Robert; Guido Schwarzer; Jerome Seidenfeld; Olaf Weingart; Chris Hyde; Andreas Engert; Julia Bohlius
Journal:  Cochrane Database Syst Rev       Date:  2012-12-12

3.  Sublethal radiation injury uncovers a functional transition during erythroid maturation.

Authors:  Scott A Peslak; Jesse Wenger; Jeffrey C Bemis; Paul D Kingsley; Jenna M Frame; Anne D Koniski; Yuhchyau Chen; Jacqueline P Williams; Kathleen E McGrath; Stephen D Dertinger; James Palis
Journal:  Exp Hematol       Date:  2011-02-01       Impact factor: 3.084

4.  EPO-mediated expansion of late-stage erythroid progenitors in the bone marrow initiates recovery from sublethal radiation stress.

Authors:  Scott A Peslak; Jesse Wenger; Jeffrey C Bemis; Paul D Kingsley; Anne D Koniski; Kathleen E McGrath; James Palis
Journal:  Blood       Date:  2012-08-13       Impact factor: 22.113

5.  Pharmacokinetics of darbepoetin alfa after intravenous or subcutaneous administration in patients with non-myeloid malignancies undergoing chemotherapy.

Authors:  Anne C Heatherington; Christian Dittrich; John T Sullivan; Greg Rossi; Johannes Schueller
Journal:  Clin Pharmacokinet       Date:  2006       Impact factor: 6.447

Review 6.  Apoptosis in the development of the immune system: growth factors, clonal selection and bcl-2.

Authors:  N J McCarthy; C A Smith; G T Williams
Journal:  Cancer Metastasis Rev       Date:  1992-09       Impact factor: 9.264

7.  Pharmacodynamics of recombinant human erythropoietin in murine bone marrow.

Authors:  Peter J Bugelski; Thomas Nesspor; Amy Volk; Joanne O'Brien; Dorie Makropoulos; Kim Shamberger; Paul W Fisher; Ian James; Danielle Graden; Renold J Capocasale
Journal:  Pharm Res       Date:  2007-07-04       Impact factor: 4.200

Review 8.  Epigenetic modifiers in normal and aberrent erythropoeisis.

Authors:  Sriram Sundaravel; Ulrich Steidl; Amittha Wickrema
Journal:  Semin Hematol       Date:  2020-12-29       Impact factor: 3.851

9.  CaM kinase IV regulates lineage commitment and survival of erythroid progenitors in a non-cell-autonomous manner.

Authors:  G A Wayman; M J Walters; K Kolibaba; T R Soderling; J L Christian
Journal:  J Cell Biol       Date:  2000-11-13       Impact factor: 10.539

10.  A prolactin-dependent, metastasising rat mammary carcinoma as a model for endocrine-related tumour dormancy.

Authors:  J H Wijsman; C J Cornelisse; R Keijzer; C J van de Velde; J H van Dierendonck
Journal:  Br J Cancer       Date:  1991-09       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.